Side effects of Mounjaro 2.5mg: what the starter dose actually feels like

Your first injection: the experience many people describe

You've collected your first Mounjaro pen, chosen your injection site (abdomen, thigh or upper arm) and pressed the button. The next 24 to 48 hours are when most people notice the most. Nausea is the most commonly reported effect: not always dramatic, often described as a low-grade unsettled feeling, as if you've eaten a large meal late at night and your stomach hasn't quite caught up. Some people experience it; a meaningful proportion don't feel much at all.

Loose stools or constipation can both appear in the first week, sometimes one follows the other. Indigestion and burping are also common, a direct consequence of how tirzepatide slows the rate at which the stomach empties. Fatigue and mild headache appear less frequently, but they're documented in the clinical data and worth knowing about. The NHS medicines information for tirzepatide lists these effects alongside the SmPC, so the pattern is well characterised. If you'd like to understand how the side-effect profile tends to shift once the dose increases, the page on moving from 2.5mg to 5mg covers that transition in detail.

One misconception worth gently setting aside: many people come to the starter dose expecting it to feel like a full therapeutic dose, stronger effects, faster change. The 2.5mg pen exists precisely so those GI symptoms stay manageable, and our dedicated page on side effects of Mounjaro 2.5 walks through what people at this specific strength most commonly report. The experience at this strength is deliberately gentler than what comes later.

Why the 2.5mg dose produces the side effects it does

Tirzepatide activates two receptors simultaneously (GIP and GLP-1) both involved in how the gut signals fullness and regulates digestion. When the stomach empties more slowly than usual, the downstream effects show up as nausea, reflux and changes in bowel habit. This isn't a sign something is going wrong; it's the pharmacological mechanism at work. The NHS page on tirzepatide sets this out clearly for patients, and it's worth a read before your first injection.

The dual-receptor action is also what distinguishes Mounjaro from semaglutide-based treatments, you can read more about the full Mounjaro mechanism and licence on our Mounjaro overview page. At 2.5mg, the receptor stimulation is lower than at maintenance doses, which is why side effects here are typically less intense than what some people experience later in their titration schedule.

Practical things that seem to help at this stage: eating smaller portions (appetite reduction often makes this natural), staying well hydrated, avoiding very fatty meals (which amplify the gastric-emptying effect) and timing your injection for a day when you can rest if needed. These aren't medical instructions; your prescriber and the patient information leaflet are the right place for personalised guidance on managing symptoms.

When side effects at this dose need medical attention

Most people move through the 2.5mg period without any serious concerns. But some symptoms shouldn't be waited out. In January 2026, the MHRA issued a Drug Safety Update on GLP-1 medicines highlighting acute pancreatitis as an uncommon but serious risk: severe stomach pain that persists and radiates toward the back (with or without vomiting) warrants urgent medical review, not a wait-and-see approach. If that describes what you're experiencing, contact NHS 111 or go to A&E.

Other reasons to seek prompt help include signs of a serious allergic reaction (swelling of the face, difficulty breathing, rapid heartbeat), persistent vomiting or diarrhoea that leaves you unable to keep fluids down, and symptoms of gallbladder problems such as sudden pain in the upper right abdomen. Injection-site reactions (redness, itching, a small lump) are common and not usually a reason for concern, but if they spread or worsen, speak to your prescriber. Our support team is available seven days a week if you're unsure and want a clinical view quickly.

You can also report any suspected side effect directly to the MHRA through the Yellow Card scheme, the link is on the bullet list above. Reporting matters: it helps regulators build a clearer picture of how these medicines perform in real-world use. If you want a broader comparison of what to expect as doses progress, the 5mg side-effect page and the page covering the 7.5mg experience give a sense of how the profile can evolve, while those approaching the higher end of the titration schedule may find our guide to 10mg Mounjaro side effects a useful reference for what that stage can bring.

Getting started safely through a clinical consultation

Mounjaro is a prescription-only medicine, which means the conversation with a prescriber isn't a formality, it's where suitability is properly established. At nume, a GPhC-registered prescriber reads your consultation personally, the same day you submit it. Not software. A person with clinical accountability.

That review covers your medical history, any medicines you're already taking and your reasons for seeking treatment, all of which shape whether 2.5mg is the right place to start, and what to watch for specifically in your case. If you'd like to explore whether Mounjaro fits your situation, our weight-loss treatments page is where consultations begin. The FAQs also cover common questions about the process if you'd like a sense of what to expect before you start. For a broader look at our approach and the clinical standards we hold ourselves to, the about us page sets that out plainly. There's no subscription, no auto-renewal, and every repeat order goes through the same clinical re-review.